Completed
Randomized Evaluation of Long Term Anticoagulant Therapy (RE-LY) With Dabigatran Etexilate
NCT00262600
- Conditions
- Arrhythmias, Cardiac, Atrial Fibrillation, Brain Diseases, +9 more
- Locations
-
- 1160.26.0009 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
- 1160.26.0046 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
- 1160.26.0057 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States
- 1160.26.0211 Boehringer Ingelheim Investigational Site Birmingham, Alabama, United States